☆ 4.2 Article

Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid-19 and non-covid-19 patients

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2023)

Related references

Note: Only part of the references are listed.

Article Neurosciences

Case series of intravenous thrombolysis for acute ischemic stroke in confirmed COVID-19 patients: single-centre experience

Ahmad Sulaiman Alwahdy et al.

Summary: This article discusses the outcomes of using IV TPA to treat acute ischemic stroke in COVID-19 patients and points out that the risk-benefit ratio remains unclear. It is suggested that IV TPA should be administered promptly in COVID-19 patients.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2022)

Add to Collection

Article Endocrinology & Metabolism

Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in Patients Hospitalized With COVID-19

Tom Norris et al.

Summary: This study investigated the association between admission blood glucose levels and in-hospital cardiovascular and renal complications in COVID-19 patients. Results showed a nonlinear association between glucose levels and complications, with age and diabetes status potentially modifying this relationship.

DIABETES CARE (2022)

Add to Collection

Article Neurosciences

Stroke in patients with COVID-19: Clinical and neuroimaging characteristics

Alberto Vogrig et al.

Summary: Acute cerebrovascular disease, particularly ischemic stroke, has been identified as a serious complication of COVID-19 infection, caused by SARS-CoV-2. Specificities in COVID-19-associated stroke cases include large vessel occlusion, multi-territory stroke, and involvement of uncommonly affected vessels. The pathogenesis of ischemic stroke in COVID-19 patients is still uncertain, but evidence suggests it may be related to cytokine storm-induced coagulopathy and endotheliopathy. Specific management challenges include difficulty in identifying stroke in critically ill patients and the need for a protected pathway for brain imaging and thrombectomy.

NEUROSCIENCE LETTERS (2021)

Add to Collection

Article Clinical Neurology

Alteplase and Adjuvant Therapies for Acute Ischemic Stroke

Adam L. Gottula et al.

Summary: Acute ischemic stroke is a time-sensitive medical emergency with IV alteplase being the only proven effective medication currently, while endovascular thrombectomy has broadened treatment options. Rapid treatment remains a priority and the future standard of treatment for AIS is still uncertain, with the importance of imaging selection for both interventions being increasingly supported by evidence.

SEMINARS IN NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry

Maria E. Ramos-Araque et al.

Summary: This study evaluated clinical predictors of cryptogenic stroke, short-term functional outcomes, and in-hospital mortality among patients with COVID-19 associated stroke. Among 14,483 laboratory-confirmed COVID-19 patients, 1.1% were diagnosed with acute ischemic stroke, with cryptogenic stroke being the most frequently reported etiology.

BMC NEUROLOGY (2021)

Add to Collection

Review Neurosciences

Potential mechanisms of cerebrovascular diseases in COVID-19 patients

Manxue Lou et al.

Summary: This review summarizes the impact of COVID-19 infection on cerebrovascular diseases, including ACE2, renin-angiotensin system, neutrophil extracellular traps, inflammatory cascade, antiphospholipid antibodies, and hyperglycemia.

JOURNAL OF NEUROVIROLOGY (2021)

Add to Collection

Article Clinical Neurology

Acute Ischemic Stroke and COVID-19 An Analysis of 27 676 Patients

Adnan Qureshi et al.

Summary: Acute ischemic stroke is rare in patients with COVID-19 and is usually accompanied by other cardiovascular risk factors. The risk of discharge to a destination other than home or death doubles with the occurrence of acute ischemic stroke in patients with COVID-19.

STROKE (2021)

Add to Collection

Article Neurosciences

Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19

Thiago Carneiro et al.

Journal of Stroke & Cerebrovascular Diseases (2021)

Add to Collection

Article Clinical Neurology

Clinical and Radiological Characteristics of Acute Cerebrovascular Diseases Among Egyptian Patients With COVID-19 in Upper Egypt

Eman M. Khedr et al.

Summary: In Egypt, the proportion of acute cerebrovascular disease among COVID-19 patients is relatively high, with large vessel occlusion being the most common. Hypertension, ischemic heart disease, and anemia are the most common risk factors, while comorbidities are prevalent, including elevated liver enzymes and creatinine partially due to COVID-19 infection itself.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Neurosciences

Stroke Mechanism in COVID-19 Infection: A Prospective Case- Control Study

Mehmet Akif Topcuoglu et al.

Summary: Patients with acute ischemic stroke and COVID-19 infection tended to have more severe strokes, delayed hospital admission, longer hospital stay, and higher mortality rates, but their vascular risk factors/comorbidities and stroke etiological subtype were similar to those without COVID-19 infection. COVID-19 positive patients also showed significantly higher levels of inflammatory markers and lower lymphocyte count. However, no significant differences were found in terms of antiphospholipid antibodies and hereditary thrombophilia between COVID-19 positive and negative patients.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Add to Collection

Article Neurosciences

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

Payam Sasanejad et al.

Summary: This multicenter study found that the use of IV-tPA for acute ischemic stroke in COVID-19 patients did not increase the risks of disability, mortality, and hemorrhagic transformation compared to those without COVID-19.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Add to Collection

Article Clinical Neurology

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke

Joan Marti-Fabregas et al.

Summary: The study evaluated the impact of COVID-19 infection on patients with ischemic stroke, finding that infected patients had more severe strokes and higher mortality rates, but similar functional outcomes compared to the non-infected group.

STROKE (2021)

Add to Collection

Article Clinical Neurology

COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

J. M. Katz et al.

Summary: This study found that in patients hospitalized for severe COVID-19, stroke occurrence is often associated with higher levels of inflammatory markers, multivascular distributions, and associated hemorrhage. The clinical data of these patients show more severe inflammation and organ damage.

AMERICAN JOURNAL OF NEURORADIOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals

Eman M. Khedr et al.

Summary: COVID-19 can lead to acute neurological complications in both the central and peripheral nervous systems, with manifestations such as stroke, seizures, encephalitis, and relapse of multiple sclerosis. Neurological symptoms are common in COVID-19 patients, including headache, vertigo, and depression.

NEUROEPIDEMIOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Soo Lim et al.

Summary: Initial studies have shown that patients with diabetes mellitus have a higher risk of severe COVID-19, potentially due to hyperglycaemia affecting immune and inflammatory responses. Further investigation is needed to determine the optimal management for patients with diabetes mellitus during the ongoing pandemic.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Add to Collection

Article Clinical Neurology

Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report

Vincent A. LaBarbera et al.

Summary: Systemic heparinization was used as an adjunct treatment modality for acute ischemic stroke patients with COVID-19-induced hypercoagulability, following thrombolysis with intravenous t-PA. This approach may be considered after multidisciplinary collaboration and family discussion.

NEUROHOSPITALIST (2021)

Add to Collection

Article Clinical Neurology

Delays in Stroke Onset to Hospital Arrival Time During COVID-19

Kay-Cheong Teo et al.

STROKE (2020)

Add to Collection

Article Clinical Neurology

SARS-CoV-2 and Stroke in a New York Healthcare System

Shadi Yaghi et al.

STROKE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Sarju Ganatra et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Add to Collection

Article Clinical Neurology

Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy

Alberto Benussi et al.

NEUROLOGY (2020)

Add to Collection

Letter Medicine, General & Internal

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Thomas J. Oxley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Clinical Neurology

Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019

Ahmad Sweid et al.

INTERNATIONAL JOURNAL OF STROKE (2020)

Add to Collection

Article Clinical Neurology

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

Yanan Li et al.

STROKE AND VASCULAR NEUROLOGY (2020)

Add to Collection

Review Neurosciences

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights

Afshin A. Divani et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Add to Collection

Review Neurosciences

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression

Raymond Pranata et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

Ying-Kiat Tan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Add to Collection

Article Clinical Neurology

Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak Clinical Characteristics and Paraclinical Findings

Shahram Majidi et al.

STROKE (2020)

Add to Collection

Article Neurosciences

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19

Thiago Carneiro et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Add to Collection

Review Clinical Neurology

tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?

Jong S. Kim

JOURNAL OF STROKE (2019)

Add to Collection

Article Clinical Neurology

Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population

M. G. Delgado et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Add to Collection

Article Clinical Neurology

Extent of early ischemic changes on computed tomography (CT) before thrombolysis - Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II

I Dzialowski et al.

STROKE (2006)

Add to Collection

Article Medicine, General & Internal

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy

PA Barber et al.

LANCET (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.